Literature DB >> 162849

Combined modality therapy for intracranial tumors.

H J Bloom.   

Abstract

Three types of tumor (supratentorial astrocytoma, medulloblastoma, and craniopharyngioma), each requiring a fundamentally different therapeutic approach, will be used to illustrate the principles and practice of combined treatment in this field. The role of radiotherapy and ways of enhancing the effect of irradiation will be considered. Attention will be given to adjuvant chemotherapy and to multiple drug regimes. Reference will be made to an early effort at immunotherapy following the initial reduction of tumor cell load by surgery and irradiation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 162849     DOI: 10.1002/1097-0142(197501)35:1<111::aid-cncr2820350116>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

Review 1.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Measurements of the volume and density of intracerebral tumors by CT following therapy.

Authors:  K Kretzschmar; K H Schicketanz
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

Review 3.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

4.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. II. Psychosocial situation and pituitary function.

Authors:  M Sääf; M Thorén; C G Bergstrand; G Norén; T Rähn; L Tallstedt; E O Backlund
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

5.  Gamma knife surgery for craniopharyngioma.

Authors:  D Prasad; M Steiner; L Steiner
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.

Authors:  A A Epenetos; N Courtenay-Luck; D Pickering; G Hooker; H Durbin; J P Lavender; C G McKenzie
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

7.  Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.

Authors:  G Comella; G Scoppa; M De Marco; G P Ianniello; G Melillo; F Coucourde; D Zarrilli
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

8.  Long-term follow-up of children with craniopharyngioma.

Authors:  N Stahnke; G Grubel; I Lagenstein; R P Willig
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

9.  New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

Authors:  Argirios Moustakas; Teri N Kreisl
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  Retreatment of recurrent cystic craniopharyngioma with chromic phosphorus P 32.

Authors:  P P Kumar; R R Good; F M Skultety; E O Jones; W K Chu
Journal:  J Natl Med Assoc       Date:  1986-06       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.